Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer
If you attended the Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer session held Friday, May 5, 2017 at the AACE Annual Meeting in Austin, TX, please proceed to attempt this assessment for ABIM Maintenance of Certification (MOC) credit. To begin, select the red 'Take Course' tab. You must be logged in to access the assessment.
- AACE Members: login with the same username/password used for the AACE website.
- Non-AACE Members: login using the non-member portal if you have an existing non-member account OR create an account if you are new to the AACE Education website.
Once logged in, you will be prompted to enter the access code you received onsite (found on page 7 of the Schedule-at-a-Glance). If you need assistance, please contact firstname.lastname@example.org.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website.
Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
- Describe major changes in the 2015 ATA Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer and how these should be applied in clinical practice
- Implement the latest ultrasound risk stratification model in choosing which patients with thyroid nodules should undergo fine-needle aspiration biopsy and which patients can be monitored
- Apply risk stratification and response to therapy as modifiers of recurrence risk to personalize long-term management and monitoring in patients with DTC
- Understand how the new ATA guidelines change perioperative (pre- and post-op) management
- Understand how the new ATA guidelines change surgical strategies
- Be familiar with the pivotal studies that have served as the underpinnings for these surgical management recommendations
- Review clinical characteristics of resistant thyroid cancer
- Review expected clinical outcomes in resistant thyroid cancer
- Review treatment options in resistant thyroid cancer
- Compare the 2015 ATA guidelines with the previously published guidelines
- Understand the 2015 guidelines
- Ensure that the 2015 guidelines are put in the proper clinical context
Peter Singer, MD; Bryan R. Haugen, MD; Julie Ann Sosa, MD; R. Michael Tuttle, MD
- 2.75 MOC